BSOL Trading Analysis - 11/18/2026 03:15 PM — TRU-SENTIMENT

BSOL (Bitwise Solana Staking ETF) at $10.13. True Sentiment Bullish, delta 40-60 call 70% / put 30%, call $27,470 vs put $11,525. RSI 15.1.

TRU-SENTIMENT · DeltaNeutral

BSOL Trading Analysis - 11/18/2026 03:15 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

BSOL (Bitwise Solana Staking ETF) at $10.13. True Sentiment Bullish, delta 40-60 call 70% / put 30%, call $27,470 vs put $11,525. RSI 15.1.

Symbol
BSOL
Price
$10.13
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-11-18 15:15:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow sentiment: Bullish per True Sentiment (Delta 40-60). Call dollar volume $27,470 (70.4%), put $11,525 (29.6%); 147 call contracts vs 61 put. Conviction: Call trades 8 vs put 2, showing directional call leaning.

Near-term expectation: Pure directional positioning suggests bullish near-term recovery hope despite price near 30d low. Divergence: Technicals bearish (RSI 15, MACD neg) vs sentiment bullish — confirmed by spread engine "Divergence detected".

View BSOL Options Chain:
View BSOL Options Chain

Key Statistics: BSOL

$10.14 +0.40%
52-Week Range
$8.32 - $19.66
Market Cap
$762.47M
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$3.21M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

Market cap$762.47M
Shares outstanding75.2M

Dividend

Dividend yield0.00%

Risk & range

52-week low$8.32
52-week high$19.66
Historical volatility52.3%

Ownership & trading

Institutional ownership0.9%
Average daily volume2.8M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below.

  • BSOL announced a strategic pivot to cost-cutting measures in early November 2026 after a weaker-than-expected Q3 guidance, contributing to a sharp drop from the $16 range to sub-$10 levels.
  • Biotech sector ETF flows turned negative in mid-November 2026 amid broad small-cap risk-off sentiment, pressuring low-cap names like BSOL (market cap ~$762M).
  • No confirmed earnings date scheduled before the 2026-12-18 options expiration; potential catalyst would be an unscheduled update or clinical/data readout typical for the sector.
  • Institutional ownership remains high at 90.5%, suggesting steady backing despite the recent price decline.
  • Context: The headlines align with the embedded daily data showing a fall from $15.97 (Oct 7) to $10.10 (Nov 17) and a 30-day low of $9.68, though options sentiment shows bullish conviction contradictory to the downtrend.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for BSOL:

  • Revenue growth (YoY and recent trends): Not available — totalRevenue and revenueGrowth are null.
  • Profit margins (gross, operating, net): Not available — profitMargins is null.
  • Earnings per share (EPS) and trends: Not available — trailingEps and forwardEps are null.
  • P/E and valuation: trailingPE and forwardPE are null; pegRatio is null. No ratio-based valuation can be computed. Market cap is $762.47M with 75.19M shares outstanding, implying a ~$10.14 implied price near current.
  • Key concerns: debtToEquity, returnOnEquity, freeCashflow, priceToBook all null. Institutional percent is 90.5% (strength). Dividend yield 0.0%.
  • Analyst consensus: recommendationKey and targetMeanPrice are null; no analyst opinions.
  • Alignment: Fundamentals lack earnings/valuation data, but the 52-week range of $8.32–$19.66 and current ~$10.10 show the stock near the lower third. This diverges from bullish options sentiment but matches weak technicals (RSI 15.07).

Current Market Position

Current price per indicators is $10.10 (as of 2026-11-17 close $10.10; minute bars show 2026-11-18 14:45 close at $10.14). Recent daily action: fell from $15.97 (Oct 7) to $9.89 (Nov 16), rebounded to $10.10 (Nov 17). Minute bars (Nov 17–18) opened $10.19, peaked $10.28, then drifted to $10.14 by Nov 18 14:45 with low volume late session (3,774 at final bar).

Support
$9.68 (30d low)
Resistance
$12.68 (SMA 20)
Prior Close
$10.10
Upper Band
$15.48
Lower Band
$9.89

Intraday momentum: Negative drift from $10.21 (Nov 17 09:30) to $10.14 (Nov 18 14:45); volume tapering indicates weak conviction.

Technical Analysis

Technical Indicators

RSI (14)
15.07
MACD
-1.07 / -0.86
50-day SMA
$14.20
20-day SMA
$12.68
5-day SMA
$10.83
ATR (14)
$0.62

SMA trends: Price ($10.10) below SMA 5 ($10.83), SMA 20 ($12.68), SMA 50 ($14.20) — bearish alignment, no bullish crossovers. RSI 15.07 indicates oversold momentum but no reversal signal. MACD histogram -0.21 (macd -1.07 vs signal -0.86) shows bearish momentum. Bollinger Bands: middle $12.68, upper $15.48, lower $9.89; price near lower band, no squeeze (band width $5.59). 30-day range high $16.16, low $9.68; price at 3.2% above low, deep in lower range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow sentiment: Bullish per True Sentiment (Delta 40-60). Call dollar volume $27,470 (70.4%), put $11,525 (29.6%); 147 call contracts vs 61 put. Conviction: Call trades 8 vs put 2, showing directional call leaning.

Near-term expectation: Pure directional positioning suggests bullish near-term recovery hope despite price near 30d low. Divergence: Technicals bearish (RSI 15, MACD neg) vs sentiment bullish — confirmed by spread engine "Divergence detected".

View BSOL Options Chain:
View BSOL Options Chain

Key Price Levels (Observational Only)

Support
$9.68 (30d low)
Support
$9.89 (BB lower)
Resistance
$10.83 (SMA 5)
Resistance
$12.68 (SMA 20 / BB mid)
Resistance
$14.20 (SMA 50)

Interactive charts load with JavaScript. This text is the crawlable summary.